FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Torvexadiclofenac sodium and menthol, methyl salicylate | — | Kit | Florrax Pharmaceutical | Sep 25, 2026 | 84460-805 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | Sep 24, 2026 | 0781-2727 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | Sep 24, 2026 | 0781-2728 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | Sep 24, 2026 | 0781-2729 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | Sep 24, 2026 | 0781-2730 |
| Glimepiride | Glimepiride 4 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | Sep 24, 2026 | 68788-4191 |
| hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | Sep 24, 2026 | 68788-4192 |
| divalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Film coated, Extended releaseOral | Preferred Pharmaceuticals Inc. | Sep 24, 2026 | 68788-4193 |
| Diclofenac Sodium Delayed Releasediclofenac sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | Preferred Pharmaceuticals Inc. | Sep 24, 2026 | 68788-4194 |
| Lidocaine | Lidocaine 50 mg/g | OintmentTopical | Preferred Pharmaceuticals Inc. | Sep 24, 2026 | 68788-4195 |
| Gemfibrozil | Gemfibrozil 600 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | Sep 24, 2026 | 70518-4764 |
| Clonazepam | Clonazepam .5 mg/1 | TabletOral | Unit Dose Solutions, Inc. | Sep 24, 2026 | 87441-090 |
| Lorazepam | Lorazepam 1 mg/1 | TabletOral | Unit Dose Solutions, Inc. | Sep 24, 2026 | 87441-091 |
| ONSWIK KwikPeninsulin efsitora alfa-gobe | Insulin efsitora alfa 500 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | Sep 23, 2026 | 0002-5137 |
| ONSWIK KwikPeninsulin efsitora alfa-gobe | Insulin efsitora alfa 1000 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | Sep 23, 2026 | 0002-5240 |
| Lanreotide Acetate | Lanreotide acetate 120 mg/.5mL | InjectionSubcutaneous | Amneal Pharmaceuticals LLC | Sep 23, 2026 | 70121-2517 |
| ziprasidone | Ziprasidone hydrochloride 20 mg/1 | CapsuleOral | REMEDYREPACK INC. | Sep 23, 2026 | 70518-4761 |
| Doxycycline | Doxycycline 100 mg/1 | CapsuleOral | REMEDYREPACK INC. | Sep 23, 2026 | 70518-4762 |
| gabapentin | Gabapentin 300 mg/1 | CapsuleOral | REMEDYREPACK INC. | Sep 23, 2026 | 70518-4763 |
| Amlodipine Besylate | Amlodipine besylate 2.5 mg/1 | TabletOral | Direct_Rx | Sep 23, 2026 | 72189-689 |
| Carvedilol | Carvedilol 12.5 mg/1 | Tablet, Film coatedOral | Direct_Rx | Sep 23, 2026 | 72189-690 |
| Tramadol Hydrochloride | Tramadol hydrochloride 50 mg/1 | Tablet, CoatedOral | Unit Dose Solutions, Inc. | Sep 23, 2026 | 87441-089 |
| Chlorhexidine Gluconate | Chlorhexidine gluconate 1.2 mg/mL | RinseOral | Xttrium Laboratories, Inc. | Sep 22, 2026 | 0116-1999 |
| clonidine hydrochloride | Clonidine hydrochloride .05 mg/1 | TabletOral | Alembic Pharmaceuticals Inc. | Sep 22, 2026 | 62332-169 |
| Lidocaine | Lidocaine 50 mg/g | PatchTopical | Ascend Laboratories, LLC | Sep 22, 2026 | 67877-767 |